The immunoengineering field is transforming cancer, autoimmunity, regeneration, and transplantation treatments by combining the diverse and complex fields of engineering and immunology. This symposium will highlight some of the latest advances in immunoengineering with a focus on translational aspects of the field. It is also a celebration of the Johns Hopkins Translational Immunoengineering Center renewal and its accomplishments.
Date and Time
March 11, 2026 from 8:00 am – 1:00 pm ET.
Location and Directions
Chevy Chase Auditorium in the Sheikh Zayed Tower building, Johns Hopkins Hospital
View the campus map or download the Johns Hopkins Find Your Way App to help you navigate the campus.
Keynote Speakers
Krishnendu Roy, PhD
Bruce and Bridgitt Evans Dean of EngineeringUniversity Distinguished Professor, Vanderbilt University
Engineering Fully Immunocompetent Microphysiological Systems for Understanding Human Immunity in Infectious Diseases and Cancer
Haig Aghajanian, PhD
Founder of Capstan Therapeutics
Adjunct Assistant Professor of Medicine, University of Pennsylvania
In Vivo CAR T Therapy: From Bench to Bedside
Agenda
Stop at the registration table to check-in, get your badge, and get the QR code for the agenda.
Jonathan Schneck, MD, PhD
Professor of Pathology, Medicine, and Oncology, Johns Hopkins University
Co-PI, Johns Hopkins Translational Immunoengineering
Biography
Jordan Green, PhD
Herschel L. Seder Professor of Biomedical Engineering, Ophthalmology, Oncology, Neurosurgery, and Materials Science & Engineering, Johns Hopkins University School
Co-PI, Johns Hopkins Translational Immunoengineering
Biography
Krishnendu Roy, PhD
Bruce and Bridgitt Evans Dean of EngineeringUniversity Distinguished Professor, Vanderbilt University
Engineering Fully Immunocompetent Microphysiological Systems for Understanding Human Immunity in Infectious Diseases and Cancer
Biography
Emily Ariail
Biomedical Engineering PhD Student
Expansion of Neoantigen-Specific Patient T Cells Using Neoepitope-Based Artificial Antigen
Manav Jain
Biomedical Engineering PhD Student
In Vivo CAR T Cell Generation Of Via Broadly- And Selectively-Targeted Polymeric Mrna Nanoparticles For The Treatment Of B Cell Diseases
Jamie Spangler, PhD
William R. Brody Faculty Scholar and Associate Professor of Biomedical Engineering at Johns Hopkins University
Immunology Engineering Education through JH-TIE
Biography
Jakub Tomala, PhD
Research Assistant Professor, Johns Hopkins School of Medicine
Engineered IL-2/Antibody Fusion Proteins Confer Autoimmune Disease Protection Through Selective Expansion Of Specific Immune Cell Populations
Haig Aghajanian, PhD
Founder of Capstan Therapeutics
Adjunct Assistant Professor of Medicine, University of Pennsylvania
In Vivo CAR T Therapy: From Bench to Bedside
Biography
Event sponsored by JH-TIE, an NIBIB funded NCBIB, National Center for Biomedical Imaging and Bioengineering, and supported by the JHU Provost’s office, JHUSOM, Department of Biomedical Engineering, and Department of Pathology